Skip to main content
. Author manuscript; available in PMC: 2013 May 28.
Published in final edited form as: Pharmacol Ther. 2012 May 11;135(2):151–167. doi: 10.1016/j.pharmthera.2012.05.003

Fig. 1.

Fig. 1

The biosynthesis and degradation of glycine. Glycine (GLY) is synthesized from serine (SER) by serine hydroxymethyltransferase (SHMT) using tetrahydrofolate (THF) as cofactor and generating 5,10-methylene-tetrahydrofolate (5,10-MeTHF) and water. GLY is also synthesized de novo from CO2 and NH4+ by the glycine cleavage system that uses 5,10-MeTHF and NADH and generates THF and NAD+. GLY is metabolically removed by three pathways, specifically the SHMT-mediated synthesis of SER by SHMT, the reverse of the synthetic pathway; the conversion to CO2 and NH4+ by the glycine cleavage system, utilizing NAD+ and generating NADH, the reverse of the synthetic pathway; and a minor pathway to glyoxylate catalyzed by D-amino acid oxidase (DAAO), and the resulting glyoxylate converted to oxalate by lactate dehydrogenase (LDH), using NAD+ and generating NADH. GLY is also removed by the glycine deportation system by acylation with benzoyl-CoA, yielding N-benzoylglycine (hippuric acid; HA), which is irreversibly excreted into urine. GLY deportation is the only truly irreversible reaction of GLY homeostasis.